Clinical Trials on Infection of Upper Respiratory Tract Caused by 2019-nCoV in China

Total 344 results

Sinovac Life Sciences Co., Ltd.

Recruiting

SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients

Infection of Upper Respiratory Tract Caused by 2019-nCoV

China
Wuhan Union Hospital, China

Unknown

Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients

2019-nCoV | Immunoglobulin of Cured Patients

China
Beijing Children's Hospital
The First Affiliated Hospital of Anhui Medical University; Shengjing Hospital; China-Japan Friendship Hospital and other collaborators

Unknown

Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children

2019-nCoV

China
Jieming QU

Completed

Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus

2019-nCoV

China
Tongji Hospital

Unknown

A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia

2019-nCoV

China
First Affiliated Hospital of Zhejiang University
Ascletis Pharmaceuticals Co., Ltd.

Terminated

Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection

2019-nCoV

China
Tongji Hospital

Unknown

A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia

2019-nCoV

China
Tongji Hospital

Unknown

A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia

2019-nCoV Pneumonia

China
Tongji Hospital

Unknown

The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia

2019-nCoV Severe Pneumonia

China
AstraZeneca

Completed

VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIA

Prevention of Infectious Disease Caused by SARS-CoV-2

Japan
Shanghai General Hospital, Shanghai Jiao Tong University...

Completed

CT Scores Predict Mortality in 2019-nCoV Pneumonia

CT Scores Predict Mortality in 2019-nCoV Pneumonia

China
Chongqing Medical University

Withdrawn

Prognositc Factors in COVID-19 Patients Complicated With Hypertension

2019-nCoV

China
Second Affiliated Hospital of Wenzhou Medical University
Wanbangde Pharmaceutical Group Co., LTD

Unknown

Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19)

Novel Coronavirus Pneumonia | 2019-nCoV

China
The Second Hospital of Nanjing Medical University

Withdrawn

Washed Microbiota Transplantation for Patients With 2019-nCoV Infection

COVID-19 Complicated With Refractory Intestinal Infections

China
Yu Qin

Active, not recruiting

An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older

Prevention of COVID-19 Caused by SARS-CoV-2

China
China Academy of Chinese Medical Sciences
Guangdong Provincial Hospital of Traditional Chinese Medicine; Guang'anmen... and other collaborators

Unknown

A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection

Acute Upper Respiratory Infection

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection

Acute Upper Respiratory Infection

China
Guangzhou Yipinhong Pharmaceutical CO.,LTD

Completed

The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)

Acute Upper Respiratory Infection

China
Zhong Wang

Recruiting

Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection

Bacterial Infection | Upper Respiratory Tract Infection | Chinese Medicine | Pediatric Acute Upper Respiratory Tract Infection

China
Henan Provincial People's Hospital

Unknown

Sequential Oxygen Therapy Strategy for Patients With COVID-19 (SOTSPC)

Coronavirus Disease-2019

China
Sinocelltech Ltd.

Completed

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Coronavirus Disease 2019(COVID-19)

China
Ruijin Hospital

Recruiting

Povidone Iodine Nasal Irrigation and Gargling to Reduce Viral Load in Asymptomatic Patients With COVID-19 (SMART-CORE)

2019 Novel Coronavirus Infection

China
Peking Union Medical College Hospital

Completed

Association Between Post-covid Infection Status and Perioperative Morbidity: A Ambispective Cohort Study

COVID-19 | Complication of Surgical Procedure | Complication,Postoperative | Sars-CoV-2 Infection | Complication of Anesthesia

China
Tang-Du Hospital

Completed

Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

Coronavirus Disease 2019 (COVID-19)

China
Shanghai Jiao Tong University School of Medicine

Unknown

Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff

2019 Novel Coronavirus Infection

China
Guangzhou Institute of Respiratory Disease
Tongji Hospital; Guangzhou Eighth People's Hospital; Guangzhou Cellgenes Biotechnology...

Unknown

Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

China
Peking University People's Hospital

Completed

Bioequivalence Study of Azithromycin Capsule and Reference Formulation Sumamed * in Healthy Adult Subjects in China

Upper Respiratory Tract Infection | Skin Infection | Lower Respiratory Infection | Genital Infection | Subcutaneous Tissues Infection

China
Daping Hospital and the Research Institute of Surgery...

Withdrawn

Non-antibiotic Prescribing for Acute Upper Respiratory Tract Infection

Acute Upper Respiratory Tract Infection

China
Yu Qin

Enrolling by invitation

Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.

Corona Virus Disease 2019(COVID-19)

China
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

Healthy Volunteer | Coronavirus Disease 2019 (COVID-19)

China
Huazhong University of Science and Technology

Completed

The Effect of Synbiotics on the Upper Respiratory Tract Infection

Gut Microbiota | Immune Function | Upper Respiratory Tract Infection

China
Beijing 302 Hospital
Maternal and Child Health Hospital of Hubei Province; Huoshenshan Hospital; VCANBIO... and other collaborators

Completed

Treatment With Human Umbilical Cord-derived Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)

Corona Virus Disease 2019(COVID-19)

China
Affiliated Hospital to Academy of Military Medical...
Beijing 302 Hospital

Unknown

A New Screening Strategy for 2019 Novel Coronavirus Infection

Novel Coronavirus Infection Pneumonia

China
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection

Coronavirus

China
The University of Hong Kong
The Research Fund for the Control of Infectious Diseases of the Food and...

Completed

Trial of Chinese Herbal Medicine in the Treatment of Upper Respiratory Tract Infections (URTIs)

Acute Upper Respiratory Tract Infections

China
Chinese University of Hong Kong
Food and Health Bureau, Hong Kong; Hospital Authority

Terminated

A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

Influenza | Upper Respiratory Tract Infection

China, Hong Kong
Beijing 302 Hospital

Unknown

Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection

Pneumonia Caused by Human Coronavirus (Disorder)

China
The First Affiliated Hospital of Guangzhou Medical...

Completed

The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19

Coronavirus Disease 2019 | Character of the Severe Patients

China
China-Japan Friendship Hospital
Wuhan University; Wuhan Central Hospital; Wuhan lung Hospital; Ai You Foundation

Unknown

Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge

Pulmonary Rehabilitation | COVID-2019 Pneumonia

China
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Coronavirus Disease 2019 (COVID-19)

China
Shanghai Junshi Bioscience Co., Ltd.

Unknown

Tolerability,Safety,Pharmacokinetic Profile and Immunogenicity of a Recombinant Humanized Anti-SARS-CoV-2 Monoclonal Antibody (JS016) for Injection in Chinese Health Subjects

COVID-19; and High Infection Risk of SARS-CoV-2

China
First Affiliated Hospital Xi'an Jiaotong University

Completed

Effectiveness of COVID-19 Vaccines Against the SARS-COV-2 Delta (B.1.617.2) (FASTER)

SARS CoV 2 Infection

China
China Academy of Chinese Medical Sciences

Unknown

A Registry Study on Reduning（a Chinese Medicine Injection）Used in Hospitals in China

Acute Tracheobronchitis | Upper Respiratory Tract Infection;

China
Ascletis Pharmaceuticals Co., Ltd.

Active, not recruiting

Study to Evaluate Safety, Tolerability, Pharmacokinetics and the Food Effect on PK of ASC10 Tablets in Healthy Subjects

SARS CoV 2 Infection

China
Fujian Provincial Hospital

Unknown

Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus (2019-nCoV)

Pneumonia Caused by Human Coronavirus

China
Dao Wen Wang

Completed

Observational Cohort of COVID-19 Patients in Hubei Province (OCCP-HP)

2019 Novel Coronavirus Disease

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Active, not recruiting

Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)

Coronavirus Disease 2019

China
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Immunogenicity and Safety Evaluation of Recombinant Novel Coronavirus Vaccine (CHO Cells) in Enhancing Immunity

Coronavirus Disease 2019

China
Guangzhou Institute of Respiratory Disease
Huizhou Municipal Central Hospital

Withdrawn

Clinical Outcomes of Patients With COVID19

Coronavirus Disease 2019

China
Shanghai Children's Medical Center

Completed

Huashi Baidu Granule in the Treatment of Pediatric Patients With Mild Coronavirus Disease 2019

Coronavirus Disease 2019

China

Clinical Trials on Infection of Upper Respiratory Tract Caused by 2019-nCoV in China

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations